Tenet Healthcare Corporation (THC)
| Market Cap | 21.30B +40.2% |
| Revenue (ttm) | 21.81B +5.4% |
| Net Income | 2.24B +51.0% |
| EPS | 25.75 +64.5% |
| Shares Out | 80.52M |
| PE Ratio | 10.27 |
| Forward PE | 12.84 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 645,410 |
| Open | 265.64 |
| Previous Close | 267.90 |
| Day's Range | 264.29 - 268.13 |
| 52-Week Range | 157.58 - 270.57 |
| Beta | 1.23 |
| Analysts | Buy |
| Price Target | 282.48 (+6.77%) |
| Earnings Date | Jul 23, 2026 |
About THC
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient... [Read more]
Financial Performance
In 2025, Tenet Healthcare's revenue was $21.31 billion, an increase of 3.07% compared to the previous year's $20.68 billion. Earnings were $1.41 billion, a decrease of -56.03%.
Financial StatementsAnalyst Summary
According to 22 analysts, the average rating for THC stock is "Buy." The 12-month stock price target is $282.48, which is an increase of 6.77% from the latest price.
News
Equal Weight ETF ROE Celebrates Key Three Year ETF Milestone
The ETF landscape has plenty of ways to signal momentum or positive news for ETFs, from tech charts to raw performance data. One key data point, however, is the three year anniversary of a fund's laun...
Tenet Healthcare Earnings Call Transcript: Q2 2026
Q2 2026 saw strong revenue and margin growth, with adjusted EBITDA up 16.3% year-over-year and EPS up 52%. Guidance for 2026 was raised across revenue, EBITDA, and free cash flow, supported by high-acuity strategies, disciplined expense management, and robust capital deployment.
Tenet Healthcare Earnings release: Q2 2026
Tenet Healthcare released its Q2 2026 earnings on July 24, 2026, summarizing the period's financial results.
Tenet Healthcare Slides: Q2 2026
Tenet Healthcare has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 24, 2026.
Tenet Healthcare Quarterly report: Q2 2026
Tenet Healthcare has published its Q2 2026 quarterly earnings report on July 24, 2026.
Why Tenet Healthcare Stock Is Surging 23% Today While This Rival Lags Behind
Tenet and HCA Healthcare present Wall Street with different pictures of their operations as the companies report second-quarter earnings.
Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended June 30, 2026. "Strong same-store revenue growth and effective expense manag...
Tenet to Report Its Second Quarter 2026 Results on July 24
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will release its second quarter 2026 results before the market opens on Friday, July 24, 2026, to be followed by a conference call at ...
Tenet Healthcare Transcript: Bank of America Global Healthcare Conference 2026
Q1 volumes improved sequentially, supporting a strong outlook and confidence in annual guidance. Growth strategies focus on high acuity services, ambulatory expansion, and operational efficiency through AI. Capital deployment prioritizes M&A and share repurchases, with a strong cash position maintained.
Tenet to Participate in the BofA Securities Health Care Conference
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the BofA Securities Health Care Conference on Wednesday, May 13, 2026.
Tenet Healthcare Earnings Call Transcript: Q1 2026
Q1 2026 saw revenues of $5.4B and adjusted EBITDA of $1.16B, both above expectations, driven by strong cost management and high-acuity growth. Guidance for 2026 is reaffirmed, with robust cash flow and continued capital deployment for M&A and share repurchases.
Tenet Healthcare Earnings release: Q1 2026
Tenet Healthcare released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Tenet Healthcare Slides: Q1 2026
Tenet Healthcare has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.
Tenet Healthcare Quarterly report: Q1 2026
Tenet Healthcare has published its Q1 2026 quarterly earnings report on April 30, 2026.
Tenet Reports Strong First Quarter 2026 Results
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended March 31, 2026. "We delivered strong results in both the Ambulatory and Hosp...
Tenet Healthcare Proxy statement: Proxy filing
Tenet Healthcare filed a proxy statement on April 16, 2026, providing details for shareholder voting and corporate governance matters.
Tenet Healthcare Proxy statement: Proxy filing
Tenet Healthcare filed a proxy statement on April 16, 2026, providing details for shareholder voting and corporate governance matters.
Tenet to Report its First Quarter 2026 Results on April 30th
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will release its first quarter 2026 results before the market opens on Thursday, April 30, 2026, to be followed by a conference call a...
Tenet Healthcare Transcript: Barclays 28th Annual Global Healthcare Conference
Strong demand for high-acuity care and disciplined capital deployment support robust growth projections. AI and automation drive efficiency, while commercial rates remain favorable and ambulatory expansion continues. Capital priorities include service line investment, share buybacks, and debt reduction.
Tenet to Participate in the Barclays 28th Annual Global Healthcare Conference
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026, beginning at 9:30 a.m. Ea...
Tenet Healthcare Earnings Call Transcript: Q4 2025
2025 saw strong revenue and margin growth, with Adjusted EBITDA up 14% and robust free cash flow. 2026 guidance anticipates continued growth, though headwinds from expiring tax credits are expected. Capital deployment remains focused on M&A, share repurchases, and technology-driven efficiencies.
Tenet Healthcare Annual report: Q4 2025
Tenet Healthcare has published its Q4 2025 annual report on February 11, 2026.
Tenet Healthcare Earnings release: Q4 2025
Tenet Healthcare released its Q4 2025 earnings on February 11, 2026, summarizing the period's financial results.
Tenet Healthcare Slides: Q4 2025
Tenet Healthcare has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 11, 2026.
Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended December 31, 2025. "2025 extended Tenet's track record of strong revenue gro...